Bioventus Inc. announced on August 29, 2022, Stavros G. Vizirgianakis resigned as a member of the Board of Directors of Bioventus Inc., effective as of that date. Mr. Vizirgianakis' resignation is not the result of any disagreement with the Company, any member of the Board, or Company management regarding any matter relating to the Company's operation, policies (including accounting or financial policies), strategic direction, or practices. At present, the Company does not expect any material change in Mr. Vizirgianakis' beneficial ownership in the Company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.17 USD | -3.25% | -11.28% | -20.87% |
Mar. 13 | Craig-Hallum Adjusts Price Target on Bioventus to $9 From $6, Maintains Buy Rating | MT |
Mar. 12 | Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.87% | 273M | |
+72.33% | 12.32B | |
-18.47% | 7.96B | |
+3.57% | 5.84B | |
+6.65% | 5.11B | |
+20.83% | 4.28B | |
-19.84% | 4B | |
-41.83% | 2.15B | |
+0.25% | 2.01B | |
+4.02% | 1.8B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- Bioventus Inc. Announces Resignation of Stavros G. Vizirgianakis as Member of the Board of Directors